By Staff Reporter |
The federal government will no longer subsidize transgender procedures for either adults or children.
On Thursday, Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. issued a declaration prohibiting gender transition procedures as valid treatments for addressing gender dysphoria.
“Sex-rejecting procedures for children and adolescents are neither safe nor effective as a treatment modality for gender dysphoria, gender incongruence, or other related disorders in minors, and therefore, fail to meet professional recognized standards of health care. For the purposes of this declaration, ‘sex-rejecting procedures’ means pharmaceutical or surgical interventions, including puberty blockers, cross-sex hormones, and surgeries such as mastectomies, vaginoplasties, and other procedures, that attempt to align an individual’s physical appearance or body with an asserted identity that differs from the individual’s sex.”
The declaration cited the HHS evidence review on pediatric gender dysphoria care published in May as justification for the cessation of funds. As part of this evidence review, HHS invited peer reviews from other major medical associations. Among those invited, the American Academy of Pediatrics and Endocrine Society declined to participate. However, the American Psychiatric Association and eight other peer reviewers submitted their own reviews, which HHS published along with their own responses last month.
Further justification for the declaration came from evidence reviews and consensus by other European nations: the United Kingdom, Sweden, Finland, Denmark, Norway, Italy, Brazil, and Australia.
Centers for Medicare & Medicaid Services (CMS) will also be proposing new rules barring hospitals which participate in Medicare and Medicaid from performing gender transition procedures, and prohibiting Medicaid from paying for those procedures.
The FDA issued warnings to around a dozen manufacturers of breast binders to cease marketing to children for gender dysphoria. Noncompliance would result in enforcement actions, including product seizures.
HHS will also be reversing the Biden administration’s efforts to make gender dysphoria a protected class within the federal definition of “disability.”
In a press conference on the declaration, Kennedy said medical professionals supportive of transgenderism had “betrayed” their oath and “moral obligation” to do no harm.
“This is not medicine, it is malpractice. We’re done with junk science driven by ideological pursuits, not the well-being of children,” said Kennedy. “Sex-rejecting procedures rob children of their futures.”
One report cited by HHS estimated that 2023 revenue for gender-transitioning drugs and surgeries exceeded $4.4 billion, a figure which is on track to exceed $7 billion by 2030.
CMS Administrator Mehmet Oz said children were sold a “dishonest narrative” about gender transitions as healthcare.
“You know what you get when you mix politics and medicine? Politics. There is no medicine left,” said Oz.
53 percent of children are in Medicaid or CHIP programs.
Oz offered a non-comprehensive list of recurring health problems within gender transition patients: puberty blockers associated with reduced bone density, altered brain development, lifelong disrupted sexual dysfunction; cross-sex hormones associated with infertility, loss of sexual function, cardiovascular issues, and long-term endocrine problems; and gender transition surgeries associated with disfiguration, pain, and mental health troubles.
Oz pointed out the high costs of the gender transition surgeries, offering examples of a vaginoplasty ($60,000) and phalloplasty ($150,000).
HHS estimates these bans will result in $250 million in savings for the taxpayer.
AZ Free News is your #1 source for Arizona news and politics. You can send us news tips using this link.
